Designing GLP-1 / analog informed-consent frameworks

This deep-dive article explains how clinics can structure informed-consent documentation for GLP‑1 / analog programs without making therapeutic claims.

1. Define what informed-consent is (and is not)

It is not a marketing form. It is a structured explanation of responsibilities, benefits/risks (in general terms), alternatives, and patient commitments.

2. Core modules

• Program framing
• General risk categories (non-specific)
• Monitoring plan
• Follow-up and adherence expectations

3. How to phrase “general risks” safely

Keep phrases high-level, avoid definitive probabilities, avoid promising outcomes.

4. Provider and patient responsibilities

Clear, simple bullet points improve comprehension.

For HCP reference only, not clinical advice.